Inflammatory parameters and soluble cell adhesion molecules in Swedish children with Kawasaki disease: relationship to cardiac lesions and intravenous immunoglobulin treatment
暂无分享,去创建一个
[1] A. Bisno,et al. Diagnostic guidelines for Kawasaki disease. , 2001, Circulation.
[2] Chini,et al. Characterization of the T‐Cell Receptor V‐β Repertoire in Kawasaki Disease , 1998, Scandinavian journal of immunology.
[3] S. Shulman,et al. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. , 1997, The Journal of pediatrics.
[4] K. Hirayama,et al. Circulating soluble selectins in Kawasaki disease , 1997, Clinical and experimental immunology.
[5] D. Leung,et al. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. , 1995, Journal of immunology.
[6] H. Igarashi,et al. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. , 1995, The Journal of infectious diseases.
[7] A. Fasth,et al. Kawasaki disease in Sweden: incidence and clinical features , 1995, Acta paediatrica.
[8] T. Carlos,et al. Leukocyte-endothelial adhesion molecules. , 1994, Blood.
[9] O. Strannegard,et al. Cytokines and other markers of intrathecal immune response in patients with herpes simplex encephalitis. , 1994, The Journal of infectious diseases.
[10] E. Giannini,et al. TCR V beta family repertoire and T cell activation markers in Kawasaki disease. , 1994, Journal of immunology.
[11] A. Maffey,et al. Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome. , 1994, The Journal of pediatrics.
[12] M. Drayson,et al. Circulating soluble adhesion molecules in systemic vasculitis. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] D. Kim,et al. Serum soluble E-selectin levels in Kawasaki disease. , 1994, Scandinavian journal of rheumatology.
[14] A. Gearing,et al. Circulating adhesion molecules in disease. , 1993, Immunology today.
[15] B. Chiang,et al. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. , 1992, The Journal of pediatrics.
[16] A. Yachi,et al. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. , 1992, Arthritis and rheumatism.
[17] H. Yanagawa,et al. Cardiac sequelae of Kawasaki disease in Japan: statistical analysis. , 1991, Pediatrics.
[18] D. Leung. The Potential Role of Cytokine‐Mediated Vascular Endothelial Activation in the Pathogenesis of Kawasaki Disease , 1991, Acta paediatrica Japonica : Overseas edition.
[19] S. Shulman,et al. Nationwide survey of Kawasaki disease and acute rheumatic fever. , 1991, The Journal of pediatrics.
[20] H. Nakano,et al. Intravenous gamma-globulin for Kawasaki disease. , 1991, Acta paediatrica Japonica : Overseas edition.
[21] F. Orson,et al. Soluble interleukin-2 receptors in children with Kawasaki syndrome. , 1990, Arthritis and rheumatism.
[22] K. Yabuta,et al. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.
[23] J. Newburger,et al. ENDOTHELIAL CELL ACTIVATION AND HIGH INTERLEUKIN-1 SECRETION IN THE PATHOGENESIS OF ACUTE KAWASAKI DISEASE , 1989, The Lancet.
[24] H. Kanegane,et al. The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses. , 1989, Clinical and experimental immunology.
[25] P. Pelkonen,et al. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. , 1989, The Journal of laboratory and clinical medicine.
[26] S. Daniels,et al. Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study. , 1986, Journal of the American College of Cardiology.
[27] J. Newburger,et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. , 1986 .
[28] H. Nakano,et al. HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE , 1983, The Lancet.
[29] H. Yanagawa,et al. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. , 1974, Pediatrics.
[30] T. Kawasaki,et al. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].
[31] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.